All Posts By

Smartkarma Daily Briefs

Daily Brief Financials: Canara Bank, BlackRock, USD, Edelweiss Financial Services, HDB Financial Services Ltd, Nesco Ltd, Nuvama Wealth Management, Yorkville Acquisition, Q & M Dental Group (Singapore), Cantor Equity Partners III and more

By | Daily Briefs, Financials

In today’s briefing:

  • Relative Value Roundup: Opportunities and Performance Recap of Pair Trades in Asia-Pacific
  • 225: Retirement Planning: What New Legislation Could Mean For Your Retirement Account
  • Global FX: Mid-Year Outlook – Tell me something new
  • Edelweiss: Last 3Y Have Seen Tremendous Shift, Next 2Y Should Be Even Better
  • HDB Financial Services: Float Cap Expansion Sets Stage for Global Index Inclusion
  • Nesco: Weak Q4FY25 Due to Underwhelming Performance in BEC
  • Nuvama: FY25 Ends To Be a Breakout Year
  • Yorkville Acquisition SPAC: Trump-Linked Ventures and Telecom-Digital Asset Focus
  • REITs and Tech led Net Institutional Inflows, as Frencken Chair and DHLT CEO Raised their Stakes
  • SPACs, Strategic Reviews, and Acquisitions: Key Developments in Special Situation Investments


Relative Value Roundup: Opportunities and Performance Recap of Pair Trades in Asia-Pacific

By Gaudenz Schneider

  • Context: This Insight follows up on previously highlighted relative value opportunities, using a statistical methodology based on mean-reversion to identify opportunities in paired securities.
  • Highlight: Three pair trade opportunities across three markets and two sectors persist.
  • Why read: Statistical analysis offers a unique perspective on relative value. Gain insights into actionable statistical pair trade opportunities and monitor performance of previously highlighted pairs.

225: Retirement Planning: What New Legislation Could Mean For Your Retirement Account

By The Bid

  • Retirement is a key focus for BlackRock, with half of their assets being retirement related
  • Recent policy changes have expanded access to workplace retirement plans in the US
  • BlackRock and the Bipartisan Policy Center have co-authored a paper with recommendations to increase access to retirement plans and improve best practices for saving and investing for retirement

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Global FX: Mid-Year Outlook – Tell me something new

By At Any Rate

  • Dollar decoupled from US rates and equities, investors expected to chase dollar lower
  • Dollar positioning not as crowded as perceived, global holdings of US equities still large
  • Unlikely for significant repatriation of Japanese foreign bond investments, focus on rebalancing rather than one-way repatriation; implications of upcoming election on Yen uncertain

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Edelweiss: Last 3Y Have Seen Tremendous Shift, Next 2Y Should Be Even Better

By Ankit Agrawal, CFA

  • Edelweiss has executed well over the past three years led by its pivot towards fee-based model. Its asset management businesses have grown rapidly, contributing significantly to the fee income.
  • The credit businesses are still struggling in terms of growth, but they have been pivoted successfully towards the co-lending model and the next couple of years could see significant growth.
  • The insurance businesses are also on track to breakeven over the next couple of years in line with the management’s prior guidance.

HDB Financial Services: Float Cap Expansion Sets Stage for Global Index Inclusion

By Dimitris Ioannidis

  • The free float is estimated to gradually increase from ~15% up to 30% over six months due to the lock-up expiries of Anchor Investors and pre-IPO Shareholders.
  • HDB Financial Services is forecasted to be added to Global All-World in December 2025 following the lock-up expiry of the Anchor Investors.
  • HDB Financial Services has a chance of inclusion in Global Standard in February 2026 following the lock-up expiry of pre-IPO shareholders which can increase free float up to 30%.

Nesco: Weak Q4FY25 Due to Underwhelming Performance in BEC

By Ankit Agrawal, CFA

  • Nesco reported a weak Q4FY25 led by weak performance in the exhibition segment (“BEC”). Revenue in the BEC segment was down -25% YoY and -30% QoQ.
  • On the other hand, the IT Parks segment performed strong. IT Parks segment’s Q4FY25 revenue grew 2% QoQ and 15%+ YoY, led by improved occupancy and rise in rental rates.
  • Typically, the Foods business is linked to the BEC business. However, in Q4FY25, despite weak BEC revenues, the Foods business did well led by the catering business.

Nuvama: FY25 Ends To Be a Breakout Year

By Ankit Agrawal, CFA

  • Nuvama Wealth Management (“Nuvama”) has consistently outperformed expectations throughout FY25 and Q4FY25 was no exception. In particular, the Asset Services sub-segment has been the outlier.
  • The Wealth Management and Asset Management segments continued to perform steadily providing resilience to the platform, despite cyclicality. They saw net inflows despite challenging market conditions during 2HFY25. 
  • Due to market volatility, certain pockets of the investment bank and institutional equities sub-segments saw somewhat muted performance, however, Nuvama fared much better relative to its peers.

Yorkville Acquisition SPAC: Trump-Linked Ventures and Telecom-Digital Asset Focus

By Special Situation Investments

  • YORKU units trade at $11, with each unit including common stock backed by a $10/share trust value and one-third of a warrant.
  • Yorkville Advisors, tied to Trump-related ventures, sponsors YORKU, with a 25% stake and a $150m IPO size.
  • YORKU targets telecom, media, and digital assets sectors, with management linked to Trump Media and potential speculative opportunities.

REITs and Tech led Net Institutional Inflows, as Frencken Chair and DHLT CEO Raised their Stakes

By Geoff Howie

  • Institutions were net sellers of Singapore stocks with a S$248 million outflow, led by STI banks’ S$2.73 billion outflow.
  • United Overseas Bank, DBS Group Holdings, and Oversea-Chinese Banking Corporation led share buybacks, totaling S$69.7 million in consideration.
  • Q & M Dental Group CEO Ng Chin Siau increased his interest to 55.78%, acquiring 7,041,300 shares via Quan Min Holdings.

SPACs, Strategic Reviews, and Acquisitions: Key Developments in Special Situation Investments

By Special Situation Investments

  • Cantor Equity Partners III (CAEP) added to tracking portfolio, trading at $10.50/share, 5% premium to trust value.
  • Nektar Therapeutics (NKTR) stock rose 150% on positive phase 2b trial data for atopic dermatitis treatment Rezpeg.
  • SmartPay Holdings (SMP:AX) definitive agreement to be acquired by Shift4 Payments at NZ$1.20/share, 7% spread remains.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Talkmed, Hims & Hers Health Inc, 3SBio Inc, Wuhan Dazhong Dental Medical, Mira Pharmaceuticals , Q & M Dental Group (Singapore), Genuine Biotech, Apellis Pharmaceuticals and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • TalkMed (TKMED SP)’s Super Clean Scheme
  • Hims & Hers Stock Nosedives: The Real Reason Behind the Novo Nordisk Breakup!
  • 3SBio Inc (1530 HK): Licensing Deal a Market Hit; Will It Continue?
  • Wuhan Dazhong Dental Medical IPO: Shine Revival Will Take a Few Sessions
  • MIRA: Data Shows Weight Drop Without Muscle Loss
  • REITs and Tech led Net Institutional Inflows, as Frencken Chair and DHLT CEO Raised their Stakes
  • Pre-IPO Genuine Biotech – The Current Pipeline Hardly Supports High Valuation
  • Apellis Pharma is Betting Big on Global Expansion for SYFOVRE; What Lies Ahead?


TalkMed (TKMED SP)’s Super Clean Scheme

By David Blennerhassett

  • On the 23 Dec 2024, tertiary health care provider TalkMed (TKMED SP)  announced an Offer, by way of a Scheme, from Tamarind Health at S$0.456/share, a 20% premium to undisturbed.  
  • Tamarind is a Singaporean-based, pan-Asian oncology-focused group. As part of the deal, Temasek-backed 65 Equity Partners will subscribe for new shares in Tamarind.
  • The Composite Document is now out, with a Court Meeting on the 15th July, and expected payment around the 29th August. The IFA (KPMG) says “fair & reasonable“. 

Hims & Hers Stock Nosedives: The Real Reason Behind the Novo Nordisk Breakup!

By Baptista Research

  • Hims & Hers Health has found itself at the center of investor turmoil after its high-profile collaboration with Novo Nordisk on FDA-approved weight loss drug Wegovy abruptly ended.
  • The Danish pharmaceutical titan terminated the pact, accusing Hims & Hers of misleading marketing practices and non-compliance with regulations governing compounded drugs—actions it deemed a threat to patient safety.
  • Hims & Hers CEO Andrew Dudum fired back, insisting the company’s compounding approach is legal under FDA rules and accusing Novo Nordisk of leveraging its market dominance to pressure patients toward branded Wegovy.

3SBio Inc (1530 HK): Licensing Deal a Market Hit; Will It Continue?

By Tina Banerjee

  • 3SBio Inc (1530 HK) signed an outlicensing deal worth more than $6B with Pfizer for its PD-1/VEGF bispecific antibody, SSGJ-707. Since signing the deal, 3SBio shares rallied more than 55%.
  • Considering deals signed with Chinese companies for bispecific antibody drug candidates in recent times, 3SBio seems to have secured best valuation for its asset.
  • Initiation of global trial of SSGJ-707 and data readout from its ongoing China trials for additional indications, continued strong financial performance, and new approvals are upcoming catalysts.

Wuhan Dazhong Dental Medical IPO: Shine Revival Will Take a Few Sessions

By Tina Banerjee

  • Wuhan Dazhong Dental Medical launched IPO aiming to raise up to HK$232 million (US$30 million). The company plans to sell 10.8 million shares at HK$20–HK$21.4 per share.
  • Wuhan Dazhong Dental Medical is a private dental services provider in Central China providing dental services under the direct chain model.
  • The IPO price is set at a premium (23%) to the price realized during Series B funding. Valuation looks attractive. But there are a few concerns to take into account.

MIRA: Data Shows Weight Drop Without Muscle Loss

By Zacks Small Cap Research

  • MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

REITs and Tech led Net Institutional Inflows, as Frencken Chair and DHLT CEO Raised their Stakes

By Geoff Howie

  • Institutions were net sellers of Singapore stocks with a S$248 million outflow, led by STI banks’ S$2.73 billion outflow.
  • United Overseas Bank, DBS Group Holdings, and Oversea-Chinese Banking Corporation led share buybacks, totaling S$69.7 million in consideration.
  • Q & M Dental Group CEO Ng Chin Siau increased his interest to 55.78%, acquiring 7,041,300 shares via Quan Min Holdings.

Pre-IPO Genuine Biotech – The Current Pipeline Hardly Supports High Valuation

By Xinyao (Criss) Wang

  • Essentially, Genuine‘s pipeline and commercialization strategy are centered around azvudine. However, the commercialization would still rely on the indications of HIV infection and COVID-19 in the short term.
  • The COVID-19 has passed, so future revenue contribution of this indication will gradually shrink. Considering the unsustainability of its future performance, we suggest excluding COVID-19 projects when considering long-term valuation.
  • The post-investment valuation after Series B financing was RMB3.56 billion. However, we are conservative about Genuine’s outlook, and we think reasonable valuation could be below RMB2 billion.

Apellis Pharma is Betting Big on Global Expansion for SYFOVRE; What Lies Ahead?

By Baptista Research

  • Apellis Pharmaceuticals, Inc., a biopharmaceutical company focused on C3 targeting therapies, reported a mixed set of results for the first quarter of 2025.
  • The quarter was marked by both achievements and challenges across their product portfolio.
  • Key products include SYFOVRE for geographic atrophy (GA) and EMPAVELI, targeting rare nephrology indications like C3G and IC-MPGN, the latter advancing toward possible FDA approval with a PDUFA date set for July 28.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Chow Tai Fook Jewellery, RPSG Ventures Limited, Aditya Birla Fashion and Retail Ltd, International Game Technology, Deliveroo, Easy Bio, Tencent Music, Sanyo Shokai, Midea Group, JD.com and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Shortlist Of High Conviction Ideas Across China, Japan, India – June 2025
  • RPSG Ventures: BPO Business Doing Well | Holding Company Discount at 82%
  • Event Driven: ABFRL~ Value Unlocking Through Strategic Demerger
  • Buy International Gaming Technologies
  • High-Conviction Arbitrage: 36% IRR Possible with 30 July Settlement, Court Approval Secured
  • Korea Small Cap Gem #37: Easy Bio Inc
  • Tencent Music (TME): Quick Note – Acquisition of Ximalaya
  • Sanyo Shokai (8011 JP): Q1 FY02/26 flash update
  • Midea Group(300 HK): Upcoming Spin-Off & IPO of ‘Annto’,Ongoing and Proposed Buyback, Strong Outlook
  • JD.com (9618 HK) Top Option Trades: Bullish Butterfly Stands Out Amond Bearish Sentiment


Shortlist Of High Conviction Ideas Across China, Japan, India – June 2025

By Sreemant Dudhoria,CFA


RPSG Ventures: BPO Business Doing Well | Holding Company Discount at 82%

By Ankit Agrawal, CFA

  • RPSG Ventures reported a strong Q4FY25 led by the BPO business that has been growing well. BPO revenues grew 3%+ QoQ and 30%+ YoY. EBIT margin has sustained at 11%+.
  • The FMCG business after posting INR 550cr+ annualized revenue run-rate for the past few quarters saw a dip in Q4FY25 with annualized revenue at INR 520cr.
  • The Sports segment reported similar revenue YoY at INR 135cr+, led by part revenue recognition from IPL 2025 that began at end of March, similar to that in 2024.

Event Driven: ABFRL~ Value Unlocking Through Strategic Demerger

By Nimish Maheshwari

  • Aditya Birla Fashion and Retail Ltd (ABFRL IN) demerged its business into two focussed entities, ABLBL(Stable Business) and ABFRL(High growth Business).
  • The separation aligns capital with business maturity isolating cash-generating lifestyle brands from high-growth, capital-hungry verticals like ethnic, luxury, and digital-first.
  • The two entities are targeting a combined INR 30,000 Cr in revenue and 3x cash profit by FY30 through unlocking sharper execution, better capital efficiency, and distinct investor appeal.

Buy International Gaming Technologies

By Richard Howe

  • International Gaming Technologies (IGT) is in the process of selling its Global Gaming and PlayDigital segments.
  • The merger arbitrage market implies a high likelihood that this deal closes soon ($14.23 share price for EVRI vs. acquisition price of $14.25).
  • Guidance is the deal could close as soon as July 1, 2025.

High-Conviction Arbitrage: 36% IRR Possible with 30 July Settlement, Court Approval Secured

By Jesus Rodriguez Aguilar

  • Deliveroo shareholders approved DoorDash’s 180p cash offer; only court sanction and procedural steps remain. Settlement could occur as early as 30 July 2025.
  • At 175.9p, the 2.33% gross spread implies a ~36.3% annualised return assuming 30-day closing.
  • Amazon counterbid now highly improbable under Rule 2.8; DoorDash bid remains dominant with 97% scenario weighting.

Korea Small Cap Gem #37: Easy Bio Inc

By Douglas Kim

  • Easy Bio Inc is one of the leaders specializing in piglet feed and animal feed additives in Korea. 
  • The company completed an excellent M&A of a company in the US called Devenish Nutrition in February 2024 for 88 billion won. 
  • If we assume a P/E of 10x and apply this on consensus net profit estimate of 36.3 billion won in 2026, this would suggest market cap of 363 billion won. 

Tencent Music (TME): Quick Note – Acquisition of Ximalaya

By Ming Lu

  • TME proposed to acquire 100% shares of Ximalaya, a long audio app.
  • TME has been exploring the long audio market since 2020.
  • We believe Ximalaya has advantages in monthly active users and car radio.

Sanyo Shokai (8011 JP): Q1 FY02/26 flash update

By Shared Research

  • Revenue decreased by 5.7% YoY to JPY14.5bn, with operating profit declining by 95.2% YoY to JPY36m.
  • Net income attributable to owners fell 93.9% YoY to JPY36m, with recurring profit down 96.6% YoY to JPY25m.
  • Despite reducing SG&A expenses by JPY400m, cost-control efforts failed to offset gross profit decline from lower revenue.

Midea Group(300 HK): Upcoming Spin-Off & IPO of ‘Annto’,Ongoing and Proposed Buyback, Strong Outlook

By Sreemant Dudhoria,CFA

  • Annto IPO: Midea Group (300 HK)plans to spin off its subsidiary Annto Logistics via a domestic IPO to unlock value in its fast-growing logistics platform.
  • Share Buyback:Midea Group Co Ltd A (000333 CH) announced a RMB 5–10 billion A-share buyback in June 2025, signaling confidence and supporting shareholder returns through disciplined capital allocation.
  • B2B Transition: Shifting from a B2C appliance maker to a tech-led B2B solution provider. With B2B contribution over 30% of revenue, it positions it for long-term, higher-margin, solution-led global growth

JD.com (9618 HK) Top Option Trades: Bullish Butterfly Stands Out Amond Bearish Sentiment

By Gaudenz Schneider

  • Context: Over the past five trading days, JD.com (9618 HK) multi-leg option strategies showcased a variety of approaches. Strategy highlights are provided.
  • Highlights: Diagonal Spreads continue to enjoy popularity. Plus, an out of the money butterfly at near zero premium demonstrates a creative application of this popular option combination.
  • Why read: This breakdown of complex option strategies sheds light on market sentiment and positioning. Detailed examples provide actionable insights that could inspire similar strategies,

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Krungthai Card, Guangzhou Automobile Group, Santos Ltd, BayCurrent Consulting , Nippon Concept, Lens Technology , Ana Holdings, Shift Up, Lens Technology and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Krungthai Card (KTC TB): Buying Opportunity After Margin Call
  • A/H Premium Tracker (To 27 June 2025):  “Beautiful Skew” Continues as SB Buys, AH Premia Fall Back
  • (Mostly) Asia-Pac M&A: Santos, PointsBet, New World Resources, SmartPay, SBI Sumishin Net Bank, Humm
  • Nikkei 225 Index Rebalance Preview (Sep 2025): Potential Adds, Deletes, PAF, Capping & Other Changes
  • Nippon Concept (9386 JP): J-STAR-Sponsored MBO a Done Deal
  • Lens Technology A/H Listing – PHIP Updates and Thoughts on A/H Premium
  • Quiddity JPX-Nikkei 400 Rebal 2025: End-June 2025 Ranks (FINAL EXPECTATIONS)
  • Lens Technology A/H Listing – Pricing Looks Decent
  • Sizing up September’s KOSPI Size Index Migration Names
  • Lens Technology H Share Listing (6613 HK): The Investment Case


Krungthai Card (KTC TB): Buying Opportunity After Margin Call

By David Blennerhassett


A/H Premium Tracker (To 27 June 2025):  “Beautiful Skew” Continues as SB Buys, AH Premia Fall Back

By Travis Lundy

  • AH premia gives back previous week gains but the “beautiful skew” of wide premia converging more than narrow premia continues. It has paid to be long wide H discounts.
  • It has paid to be long the H on those H/A pairs with the biggest H discounts. I would continue to ride that trend.
  • The data tables below update on a daily basis in the Tools section of Smartkarma. The SOUTHBOUND Flow Monitor and AH Monitor are both there free for SK readers. Technical issue delayed this week’s Monitor.

(Mostly) Asia-Pac M&A: Santos, PointsBet, New World Resources, SmartPay, SBI Sumishin Net Bank, Humm

By David Blennerhassett


Nikkei 225 Index Rebalance Preview (Sep 2025): Potential Adds, Deletes, PAF, Capping & Other Changes

By Brian Freitas


Nippon Concept (9386 JP): J-STAR-Sponsored MBO a Done Deal

By Arun George

  • Nippon Concept (9386 JP) has recommended a J-STAR-sponsored MBO at JPY3,060, a 37.2% premium to the last close price.
  • The offer is attractive as it represents an all-time high and is above the midpoint of the IFA DCF valuation range.
  • An attractive offer and irrevocables pave the way for deal completion. The tender runs from July 1 to August 13, with payment due on August 20.

Lens Technology A/H Listing – PHIP Updates and Thoughts on A/H Premium

By Sumeet Singh

  • Lens Technology (300433 CH), a precision manufacturing solution provider, aims to raise around US$1bn in its H-share listing.
  • Lens Technology (LT) is one of the leading players in precision structural parts and modules integrated solutions for both consumer electronics and smart vehicles interaction systems.
  • In this note, we look at its past performance and other deal dynamics that might impact the listing.

Quiddity JPX-Nikkei 400 Rebal 2025: End-June 2025 Ranks (FINAL EXPECTATIONS)

By Janaghan Jeyakumar, CFA

  • JPX-Nikkei 400 is composed of common stocks listed on the Tokyo Stock Exchange. It is a free-float-adjusted capped index composed of 400 constituents.
  • The annual index review takes place in August every year. We look at the latest rankings of potential ADDs/DELs every month.
  • Below is a look at the rankings of potential ADDs/DELs for the JPX-Nikkei 400 August 2025 rebalance based on trading data as of end-June 2025.

Lens Technology A/H Listing – Pricing Looks Decent

By Sumeet Singh

  • Lens Technology (300433 CH), a precision manufacturing solution provider, aims to raise around US$600m in its H-share listing.
  • Lens Technology (LT) is one of the leading players in precision structural parts and modules integrated solutions for both consumer electronics and smart vehicles interaction systems.
  • We have looked at the past performance and likely A/H premium in our previous note. In this note, we talk about the IPO pricing.

Sizing up September’s KOSPI Size Index Migration Names

By Sanghyun Park

  • Early take based on avg daily mkt cap: 5 MID→LARGE, 6 LARGE→MID. Count mismatch due to LG CNS likely making a direct jump into LARGE post-March IPO.
  • Local insto-driven moves remain tradable — in the March reshuffle, price action started from T–2M, with strongest returns in the T–1M window.
  • With cap gaps near historical norms, it’s time to pre-position around top/bottom cutline names — then scale up into borderlines as we move into the T–1M window.

Lens Technology H Share Listing (6613 HK): The Investment Case

By Arun George

  • Lens Technology (6613 HK), an industry-leading integrated one-stop precision manufacturing solution provider, has launched an H Share listing to raise US$600 million.     
  • In terms of revenue in 2024, Lens is a global leader in precision structural parts and modules integrated solutions for both consumer electronics and smart vehicle interaction systems.
  • The investment case is based on a well-performing core business, limited tariff impact, reduced reliance on Apple, strong margins, and robust cash generation. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Singapore: IFBH and more

By | Daily Briefs, Singapore

In today’s briefing:

  • IFBH IPO Trading – Strong Overall Demand, Clawback Triggered


IFBH IPO Trading – Strong Overall Demand, Clawback Triggered

By Akshat Shah

  • IFBH (6603 HK) raised about US$148m in its HK IPO.
  • IFBH specializes in ready-to-consume beverages and food, with a focus on coconut water and plant-based products.
  • We have covered various aspects of the deal in our previous note. In this note, we will talk about the demand and trading dynamics.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Monash IVF, Xero Ltd, Iron Ore, PointsBet Holdings and more

By | Australia, Daily Briefs

In today’s briefing:

  • Monash IVF (MVF AU): Embroiled in Embryo Bungle; Will the Growth Baby Be Delivered?
  • ECM Weekly (30 June 2025) – FWD, Anjoy, IFBH, HDB Financials, Virgin, Xero, Shinhan, Innovent
  • Iron Ore: Small Bounce to 100 USD/Ton On Oversold Levels
  • PointsBet Holdings Ltd – The Monday Report – 30 June 2025


Monash IVF (MVF AU): Embroiled in Embryo Bungle; Will the Growth Baby Be Delivered?

By Tina Banerjee

  • Monash IVF (MVF AU) announced that an incident occurred at its Brisbane clinic, where embryo of one patient was incorrectly transferred to another patient resulting in birth of a child.
  • The company revised the guidance of FY25 underlying NPAT to be A$27.5M from previous A$30M–31M, announced post H1FY25 results.
  • Consensus estimates predict the company’s FY26 revenue to grow marginally by 1% to A$272M and net profit to decline nearly 5%.

ECM Weekly (30 June 2025) – FWD, Anjoy, IFBH, HDB Financials, Virgin, Xero, Shinhan, Innovent

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the IPO front, in a busy listing week, the results from listing were mixed.
  • On the placements front, there were a number of large deals across the region.

Iron Ore: Small Bounce to 100 USD/Ton On Oversold Levels

By Sameer Taneja


PointsBet Holdings Ltd – The Monday Report – 30 June 2025

By FNArena

  • Wrap of events affecting the market on Friday night and the weekend and a preview of the week ahead

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: VIOL , Woori Financial Group and more

By | Daily Briefs, South Korea

In today’s briefing:

  • VIOL (335890 KS): VIG Partners’ Tender Offer And DMS’ Strategic Exit
  • Samsung F&M (000815 KS) Vs. Woori (316140 KS): No Mean Reversion (Yet), Time to Reassess the Pair


VIOL (335890 KS): VIG Partners’ Tender Offer And DMS’ Strategic Exit

By David Blennerhassett

  • VIG Partners, a PE-outfit, is seeking to delist VIOL (335890 KS), an aesthetic medical devices manufacturer, whose major shareholder, DMS (068790 KS), faces allegations of unfair internal transactions.
  • VIG first acquired 7% of DMS (068790 KS)’s 34.76% controlling stake in VIOL, following which, DMS contributed the remaining 27.76% in-kind to VIG’s SPV at a valuation of ₩12,500/share.
  • VIG’s SPV’s tender offer launched on 18th June, also at ₩12,500/share, and runs until the 7th July 7. The Offer is conditional on a minimum acceptance threshold of 20.76%.

Samsung F&M (000815 KS) Vs. Woori (316140 KS): No Mean Reversion (Yet), Time to Reassess the Pair

By Gaudenz Schneider

  • Context: This article provides an update on a previously identified pair trading opportunity between Samsung Fire & Marine Insuranc (000815 KS) and Woori Financial Group (316140 KS).
  • Key Insights: The pair has not mean-reverted.  This Insight discusses the use of a Stop Loss in a statistical pair trading context and why one might be considered at this point.
  • Why Read It: For investors interested in quantitative strategies, this article demonstrates some of the mechanics of statistical arbitrage and which indicators can be used to decide on exiting a position.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Quantitative Analysis: HK Connect Flows Weekly (Jun 27th): CCB and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • HK Connect Flows Weekly (Jun 27th): CCB, SMIC, Meituan, Guotai Junan Intl, CMB, Tencent, Alibaba
  • A-H Premium Weekly (Jun 27th): China Shenhua Energy, Bank Of Zhengzhou, Guolian Minsheng Securities
  • HK Short Interest Weekly: Baba, Chow Tai Fook, Za Online, Cspc Pharma, BOC, Petrochina
  • Thailand Short Interest Weekly (Jun 27th): Bumrungrad Hospital, Scb X, Advanced Info Service, Ptt
  • TWSE Foreign Holding Weekly (Jun 27th): Jinan Acetate Chemical, TSMC, Elite Material
  • TWSE Short Interest Weekly (Jun 27th): Hon Hai Precision, Cathay Financial, Fubon Financial
  • Bursa Short Interest Weekly (Jun 27th): Sime Darby, Dialog, Gamuda, Mr D I Y
  • KRX Foreign Holding Weekly (Jun 27th): SK Hynix, Kakaopay, Naver


HK Connect Flows Weekly (Jun 27th): CCB, SMIC, Meituan, Guotai Junan Intl, CMB, Tencent, Alibaba

By Ke Yan, CFA, FRM

  • We analyze the weekly Hong Kong Connect flows with our data engine for holding position as of June 27th.
  • The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.
  • We highlight flows for CCB, SMIC, Meituan, Guotai Junan Intl, CMB, Tencent, Alibaba, Xiaomi, BOC, Petrochina.

A-H Premium Weekly (Jun 27th): China Shenhua Energy, Bank Of Zhengzhou, Guolian Minsheng Securities

By Ke Yan, CFA, FRM

  • We analyse the changes of A-H premium on 156 stocks over the last week. The average A-H premium was 70.1% as of Jun 27th.
  • The average A-H premium changed by -2.3ppt week-on-week, led by consumer staples, financials, communication services and offset by information technology.
  • We highlight weekly changes in A-H premium for China Shenhua Energy, Bank Of Zhengzhou, Guolian Minsheng Securities, Shenwan Hongyuan, Jiangxi Copper, Cmoc.

HK Short Interest Weekly: Baba, Chow Tai Fook, Za Online, Cspc Pharma, BOC, Petrochina

By Ke Yan, CFA, FRM

  • We analyzed the latest HK SFC report for aggregate short position as of Jun 20th.
  • Top short increases and decreases were tabulated for one week and four week period.
  • We highlight short changes in Baba, Chow Tai Fook, Za Online, Cspc Pharma, BOC, Petrochina.

Thailand Short Interest Weekly (Jun 27th): Bumrungrad Hospital, Scb X, Advanced Info Service, Ptt

By Ke Yan, CFA, FRM

  • We analyzed the changes in short interest of Stock Exchange of Thailand as of Jun 27th. We estimate that they had an aggregated short interest worth USD2.0bn.
  • We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases & decreases in short value, short as multiple of ADT.
  • We highlight short interest changes in Bumrungrad Hospital, Scb X, Advanced Info Service, Ptt, Central Pattana, Cp Foods.

TWSE Foreign Holding Weekly (Jun 27th): Jinan Acetate Chemical, TSMC, Elite Material

By Ke Yan, CFA, FRM

  • We analyzed the changes in foreign holdings of TWSE Stocks as of Jun 27th. The aggregated holding was USD1,126.4bn.
  • We estimate that foreign flows to be inflows of USD16,805mln. We tabulate the league tables for top changes by value for 1W/4W/1Y and top stocks held by foreign institutions.
  • We highlight changes of foreign holdings in Jinan Acetate Chemical, TSMC, Elite Material, Evergreen Marine, UMC, China Development Financial, Cathay Financial, Asustek Computer, Quanta Computer, Uni-President Enterprises.

TWSE Short Interest Weekly (Jun 27th): Hon Hai Precision, Cathay Financial, Fubon Financial

By Ke Yan, CFA, FRM

  • We analyzed the changes in short interest of TWSE Stocks as of Jun 27th. The aggregated short interest was USD26.4bn.
  • We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases & decreases in short value, short as multiple of ADT.
  • We highlight short interest changes in Hon Hai Precision, Cathay Financial, Fubon Financial, Ase Industrial, Elite Material, Wistron, Wiwynn.

Bursa Short Interest Weekly (Jun 27th): Sime Darby, Dialog, Gamuda, Mr D I Y

By Ke Yan, CFA, FRM

  • We analyzed the changes in short interest of Bursa stocks as of Jun 27th. The aggregated short interest is USD363m.
  • We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases & decreases in short value, short as multiple of ADT.
  • We highlight short interest changes in Sime Darby, Dialog, Gamuda, Mr D I Y Group M Bhd, Kossan Rubber Industries.

KRX Foreign Holding Weekly (Jun 27th): SK Hynix, Kakaopay, Naver

By Ke Yan, CFA, FRM

  • We analyzed the changes in foreign holdings of KRX stocks as of Jun 27th. The aggregated holding was USD625.5bn.
  • We estimate that foreign flows to be inflows of USD100mln. We tabulates the league table for top changes by value for 1W/4W/1Y and top stocks held by foreign institutions.
  • We highlight changes of foreign holdings in SK Hynix, Kakaopay, Naver.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Copper and more

By | Daily Briefs, United States

In today’s briefing:

  • Copper Breaches 10k USD: Easy Journey to 11k USD/Ton On Lower Inventories In The Short Term


Copper Breaches 10k USD: Easy Journey to 11k USD/Ton On Lower Inventories In The Short Term

By Sameer Taneja

  • Inventory depletion across the LME and SHFE continued as copper prices breached the 10k USD level to end the week 3.7% higher.  
  • The COMEX-LME spread breached $1,000/ton again, leading us to be confident that there will be a further rally in the short term. 
  • We see an easy journey to 11,000 USD/ton on a weaker dollar, stronger COMEX premiums, depleted inventory levels, and lower-than-expected global production. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Guangzhou Automobile Group, Saint Bella, HKBN Ltd, Hang Seng Index, China Construction Bank H, Anjoy Foods Group, Xiaomi Corp, FWD Group Holdings, Yichang HEC Changjiang Pharma, Medtide and more

By | China, Daily Briefs

In today’s briefing:

  • A/H Premium Tracker (To 27 June 2025):  “Beautiful Skew” Continues as SB Buys, AH Premia Fall Back
  • Saint Bella IPO (2508.HK): Pricing and Post-IPO Performance, Wild Price Swings Could Be Short-Lived
  • HKBN (1310 HK): China Mobile Inches Closer Toward Precondition Satisfaction
  • Global Markets Tactical Outlook: Week of June 30 – July 4
  • HK Connect SOUTHBOUND Flows (To 27 June 2025); Volumes Up, Net Buying Up, Banks Bought, SOEs Sold
  • Anjoy Foods Group HK Offer: Value Stock or Value Trap? Key Facts, Financials and Valuation
  • Xiaomi: Sentiment Surges, Option Market Signals Overreach
  • FWD Group Holdings (1828 HK): Low Free Float Delays and Limits Global Index Inclusion
  • HEC ChangJiang Pharma (1558 HK): Finally a Vote, but the Offer Value Is Wrapped in Uncertainty
  • Medtide (泰德医药) IPO Trading Update


A/H Premium Tracker (To 27 June 2025):  “Beautiful Skew” Continues as SB Buys, AH Premia Fall Back

By Travis Lundy

  • AH premia gives back previous week gains but the “beautiful skew” of wide premia converging more than narrow premia continues. It has paid to be long wide H discounts.
  • It has paid to be long the H on those H/A pairs with the biggest H discounts. I would continue to ride that trend.
  • The data tables below update on a daily basis in the Tools section of Smartkarma. The SOUTHBOUND Flow Monitor and AH Monitor are both there free for SK readers. Technical issue delayed this week’s Monitor.

Saint Bella IPO (2508.HK): Pricing and Post-IPO Performance, Wild Price Swings Could Be Short-Lived

By Andrei Zakharov

  • Saint Bella, a leading postpartum care and recovery group in China, priced its upsized IPO at fixed offer price of HK$6.58 per share.
  • The offer size adjustment option has been fully exercised. The company issued and allotted 14,313,000 additional offer shares. 
  • Saint Bella sold 109,733,000 shares and raised net proceeds of ~HK$630M or ~$80M. The stock jumped ~49% on first day as a public company and peaked at HK$11.00 per share.

HKBN (1310 HK): China Mobile Inches Closer Toward Precondition Satisfaction

By Arun George

  • China Mobile (941 HK) has secured all PRC regulatory approvals for its HKBN Ltd (1310 HK) offer. The remaining precondition is approval from the HK Communications Authority. 
  • I Squared, while technically still in the race, is rapidly running out of time. It needs to announce an offer before China Mobile opens its offer for acceptance.
  • Despite the HKBN CEO’s comments that the China Mobile offer is not good enough, China Mobile has no pressing need to bump if a competing offer fails to materialise.

Global Markets Tactical Outlook: Week of June 30 – July 4

By Nico Rosti

  • A quick synoptic look at the tactical models for some key indices, stocks, commodities and bonds we cover, for the week June 30 – July 4.
  • US Markets will be closed for Independence Day celebrations on July 4th.
  • Most stocks and global indices appear to be overbought or nearly overbought. 10-year US Treasuries Futures are also overbought. Commodities like Gold and Crude Oil are down. 

HK Connect SOUTHBOUND Flows (To 27 June 2025); Volumes Up, Net Buying Up, Banks Bought, SOEs Sold

By Travis Lundy

  • Gross SOUTHBOUND volumes up to US$17+bn a day this past 5-day week. Net buying strong at +US$700mm a day.
  • Among the top buys as a percentage of volume, FINANCIALS stood out, dramatically. Again. Neither INFO TECH nor Tencent were the big sells this week. 
  • The data tables below update on a daily basis in the Tools section of Smartkarma. The SOUTHBOUND Flow Monitor and AH Monitor are both there free for SK readers. Technical issue delayed this week’s Monitor.

Anjoy Foods Group HK Offer: Value Stock or Value Trap? Key Facts, Financials and Valuation

By Devi Subhakesan

  • Anjoy Foods Group (2648 HK), already listed in Shanghai, is offering 40 million shares in Hong Kong to raise up to HKD2.6 billion (USD335 million); Offer closes today, June 30th.
  • HK offer is priced at a decent discount to A share price and at valuation multiples that are aligned with its peer group and business fundamentals.
  • With limited organic growth and little evidence of a strategic pivot to higher-value offerings, Anjoy Foods lacks a compelling long term investment case.

Xiaomi: Sentiment Surges, Option Market Signals Overreach

By John Ley

  • Xiaomi surged to new all-time highs following its ecosystem launch and strong YU7 pre-order momentum.
  • We examine option market activity to assess what’s being priced and whether sentiment is getting ahead of itself.
  • Two option trade structures are outlined to reflect our findings.

FWD Group Holdings (1828 HK): Low Free Float Delays and Limits Global Index Inclusion

By Dimitris Ioannidis

  • FWD Group Holdings (1828 HK) fails to meet the minimum free float thresholds of both Global indices prior to the IPO lock-up expiry.
  • The security is expected to be added to Global All-World at the September 2026 review following the 6-month lock-up expiry.
  • The security is likely to remain excluded from Global Standard even after the lock-up expiry due to insufficient float cap.

HEC ChangJiang Pharma (1558 HK): Finally a Vote, but the Offer Value Is Wrapped in Uncertainty

By Arun George

  • The precondition for Sunshine Lake Pharma’s privatisation of HEC Pharma was satisfied on 27 June. The offer is 0.263614 new offeror H Share per HEC share and HK$1.50 special dividend.
  • The vote on 21 July is low-risk as no independent H Shareholder comes close to the blocking stake, which is 4.61% of the outstanding shares (6.20% of H Shares).
  • The appraised value is HK$19.36, but this is a finger-in-the-sky valuation as it marginally increased from HK$19.30 despite the offeror’s weak 2024 results and limited progress on commercialising its pipeline.

Medtide (泰德医药) IPO Trading Update

By Ke Yan, CFA, FRM

  • Medtide raised HKD 514m (USD 65.5m) from its global offering and will list on the Hong Kong Stock Exchange on Monday, June 30th.
  • In our previous note, we looked at the company’s operation, management track records and discussed the IPO valuation.
  • In this note, we provide an update for the IPO before trading debut. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars